Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MIR3620 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NMT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBM10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EDF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RER1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPN6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TANK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COX4I1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRPF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAU - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MIR4640 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC7A8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXO7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNASEH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NR2C2AP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COL9A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MADD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUPT20H - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FABP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on